RTRAF and cervical cancer: Moreover, immunohistochemical analysis revealed that C14ORF166 was overexpressed in the majority of human cervical cancer tissue specimens tested, in agreement with previous studies in brain cancer [10] and pancreatic cancer [11, 12].